Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Share this article
Correction

Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings

R Michael Grounds1* and Charles Bolan2

Author Affiliations

1 Adult Intensive Care Unit, St George's Hospital, London, UK

2 COL (retired) US Army Medical Corps, Deputy Chief, Blood Services Section, Department of Transfusion Medicine, Clinical Centre, National Institutes of Health, Bethesda, Maryland, USA

For all author emails, please log on.

Critical Care 2005, 9:560 doi:10.1186/cc3926


The electronic version of this article is the complete one and can be found online at:


Published:4 November 2005

© 2005 BioMed Central Ltd

Correction

Following the publication of the above article [1], we noticed that the Competing interests section was incorrect and should read as follows:

RMG has worked as a consultant for Novo Nordisk and lectured on behalf of Novo Nordisk about NovoSeven.

References

  1. Grounds RM, Bolan C: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

    Crit Care 2005, 9(Suppl 5):S29-S36. PubMed Abstract | BioMed Central Full Text OpenURL